New Kantar Solution Tracks Oncology Trends

WPP-owned Kantar Health has launched a new solution called 'CancerMPact Future Trends and Insights', which can be used to explore the potential changes in oncology treatment practices in the US, Western Europe and Japan.

Based on evaluation of recently published clinical data, regulatory advances/setbacks, and ongoing clinical trials, the new tool expands on previous studies of emerging technologies and treatment trends from the firm's CancerMPact platform. New features include competitive landscape discussions within each tumor and line of therapy, expert analysis of the outlook for each competitor, and new launch timelines for each indication.

General Manager Bill Bagwell (pictured) comments: 'This updated offer explores likely competitor positioning strategies and likelihood of approval; sheds light on the potential trends and events that can pose threats to or opportunities for agents in development; and highlights opportunities for companies to develop new therapies.'

Web site: www.kantarhealth.com .